OptimizeRx Corp.

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: US68401U2042
USD
14.65
0.54 (3.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
OptimizeRx Corp.
RADCOM Ltd.
CoreCard Corp.
Innovid Corp.
ReposiTrak, Inc.
Quantum-Si, Inc.
SOPHiA GENETICS SA
FTC Solar, Inc.
Blacksky Technology, Inc.
Ryvyl, Inc.
2U, Inc.
Why is OptimizeRx Corp. ?
1
  • OPERATING CASH FLOW(Y) Highest at USD 10.66 MM
  • ROCE(HY) Highest at -8.21%
  • NET SALES(Q) At USD 29.2 MM has Grown at 55.19%
2
With ROE of -6.81%, it has a risky valuation with a 2.33 Price to Book Value
  • Over the past year, while the stock has generated a return of 230.97%, its profits have fallen by -12.7%
3
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating Performance
  • The stock has generated a return of 230.97% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to OptimizeRx Corp. should be less than 10%
  2. Overall Portfolio exposure to Software Products should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Software Products)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is OptimizeRx Corp. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
OptimizeRx Corp.
182.27%
0.36
97.05%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
29.51%
EBIT Growth (5y)
20.43%
EBIT to Interest (avg)
-4.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.56
Tax Ratio
4.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.33
EV to EBIT
-86.78
EV to EBITDA
271.52
EV to Capital Employed
2.16
EV to Sales
3.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2.49%
ROE (Latest)
-6.81%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 10.66 MM

ROCE(HY)

Highest at -8.21%

NET SALES(Q)

At USD 29.2 MM has Grown at 55.19%

PRE-TAX PROFIT(Q)

At USD 1.71 MM has Grown at 133.61%

RAW MATERIAL COST(Y)

Fallen by -6.56% (YoY

NET PROFIT(Q)

Highest at USD 1.53 MM

EPS(Q)

Highest at USD 0.08

-3What is not working for the Company
INTEREST(Q)

Highest at USD 1.6 MM

Here's what is working for OptimizeRx Corp.
Net Sales
At USD 29.2 MM has Grown at 55.19%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Pre-Tax Profit
At USD 1.71 MM has Grown at 133.61%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 1.53 MM has Grown at 138.22%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD 10.66 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit
Highest at USD 1.53 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.08
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -6.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for OptimizeRx Corp.
Interest
At USD 1.6 MM has Grown at 23.59%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest
Highest at USD 1.6 MM
in the last five periods and Increased by 23.59% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)